Ruiz-Morales, J. M., Swierkowski, M., Wells, J. C., Fraccon, A. P., Pasini, F., Donskov, F., Bjarnason, G. A., Lee, J., Sim, H., Sliwczynsk, A., Ptak-Chmielewska, A., Teter, Z., Beuselinck, B., Wood, L. A., Yuasa, T., Pezaro, C., Rini, B. I., Szczylik, C., Choueiri, T. K., & Heng, D. Y. (2016). first-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. European journal of cancer, 65, 102–108. http://access.bl.uk/ark:/81055/vdc_100035497828.0x00005b